To support public health efforts, Biocept is performing COVID-19 testing.
If you’re in need of testing, please consult with your doctor or authorized healthcare provider as Biocept will need them to order and collect the specimen for COVID-19 testing, per FDA guidance. Common FAQs, click here.
Technical information concerning the FDA-approved test kit used by Biocept to perform COVID-19 testing:
- As referenced on patient test results report, click here
- For additional information, click here and scroll to the “Resources” section at the bottom of the web page
Biocept performs testing of FDA approved protocols for Emergency Use Authorization (EUA) for COVID-19 testing and complies with the Centers for Disease Control and Prevention (CDC) guidelines on social distancing and enhanced cleaning procedures to ensure the health of our patients, employees, and others. COVID-19 Statement, click here.
For further questions, please contact Customer Service, click here.
Press release: Biocept Announces the Launch of COVID-19 Testing
Any Individual wishing to have COVID-19 testing (CPT Code U0003) should consult with their physician or authorized healthcare provider. Biocept will not perform any COVID-19 testing without a written order from a licensed healthcare provider.
Once an order is obtained, the patient should have his/her authorized healthcare provider collect the specimen and submit the specimen to Biocept. Biocept does not perform collection at its laboratory.
Biocept uses a FDA-EUA approved real-time reverse transcription polymerase chain reaction (real time RT-PCR) assay. The test detects the presence of SARS-CoV2.
Turnaround time for COVID-19 testing is generally 2-5 days from the receipt of the specimen at our laboratory. Most results can be ready within 48 hours, but may vary if we experience extraordinary demand or there are issues with the specimen.
Written test results are provided to the ordering physician or authorized healthcare provider. Biocept may also deliver test results via our secure physician portal. All results will be reported to appropriate third parties as may be required by law (e.g., CDC, CMS, etc.).
What type of specimens are required for testing?
Biocept follows the FDA and CDC recommended swab-based SARS-CoV2 collection method using a nasopharyngeal collection (NP) or oropharyngeal collection (OP) to collect an upper respiratory specimen. Once the specimen is obtained it should be placed in a collection media provided by your healthcare provider.
How are the specimens shipped?
The collected specimen must be stored at 4-25°C and shipped with a gel pack to reach our processing site within 72 hours of the specimen being obtained. If a delay in testing or shipping is expected, freeze specimen at -70 °C or below and ship overnight on dry ice. Upon request, Biocept will arrange for the specimen to be shipped to its facility.
If the patient is covered by insurance or a government health plan, such as Medicare or Medicaid, Biocept will submit any bill to such payor and by law Biocept will not seek any payment from the patient. For additional information, please see Biocept Billing Policy.
Biocept will report COVID-19 results to the appropriate public health agency in accordance with applicable legal requirements.